Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...

The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.

The campaign will spotlight educational resources and share stories of individuals and families living with glaucoma to raise ...

Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...

A study conducted on over 77,000 individuals found that alcohol consumption increased the risk of dry eye in women.

The multinational, multicenter, prospective RESTORE Study is the 5-year follow-up study of the phase 3 clinical RESCUE and ...

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...

Enhanced monofocal IOLs provide a slight depth-of-focus boost without compromising contrast, making them a versatile choice ...

Alcon Laboratories recalled Lot 10101 of Systane Lubricant Eye Drops Ultra PF due to fungal contamination, posing potential ...

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in subjects with GA ...

Artificial intelligence's potential in ophthalmology, particularly in ocular imaging, was a major focus, with debates on its ...

A Helsinki University Hospital study found diabetes, glycemic control, or insulin therapy did not significantly affect ...